Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. The Danish pharmaceutical company is offering ...

Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion, driven by the potential of bexicaserin. Bexicaserin shows promising seizure reduction ...

Longboard's stock surged 52% in premarket activity. On a fully diluted basis, the transaction is valued at about $2.5 billion net of cash, the companies said in a joint statement.

Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the former hoping to build off of its pipeline of epilepsy drug treatment.

Many people today deny the reality of original sin. Modern thinkers claim that evolution disproves it. Some object to the idea of inheriting sin from our parents, while others simply deny sin itself.

Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in ...

Although Amazon Prime Video boasts exceptional subscriber counts, the best Amazon Prime original series right now rarely capture the same attention as those from rival streaming platforms.

(RTTNews) - Danish pharmaceutical company H. Lundbeck A/S (HLUKY.PK, HLUKF.PK) and Longboard Pharmaceuticals, Inc. (LBPH), announced Monday an agreement for Lundbeck to acquire Longboard $60 per ...

Many experts predict the end of auto and truck dealerships over the next 10 to 15 years. Experts believe dealerships will fall victim to driverless vehicles, ridesharing, innovations in human ...